Form 4: Hims & Hers Health Chief Commercial Officer Executes Pre-Planned Stock Option Exercise and Sale

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed a pre-arranged transaction involving the exercise of stock options and subsequent sale of Class A Common Stock, as disclosed in a recent SEC Form 4 filing.

Summary

• Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), reported transactions on June 10, 2025, involving the company's Class A Common Stock.
• Mr. Chi acquired 5,400 shares of Class A Common Stock by exercising stock options at a price of $6.82 per share.
• Concurrently, he disposed of 5,600 shares of Class A Common Stock at a price of $57.00 per share.
• Following these transactions, Mr. Chi directly beneficially owns 256,380 shares of Class A Common Stock.
• Additionally, he holds 125,262 derivative securities (stock options) after the reported exercise.
• All reported transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Chi on March 4, 2025.
• The exercised options are part of a service-based vesting requirement, with 1/48th of the options vesting monthly since September 10, 2022, over a four-year period.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While there is insider selling, it was pre-planned under a 10b5-1 plan, which mitigates negative interpretations. The significant difference between the exercise price and sale price highlights the value realized by the executive from vested options.

Positives

• The sale price of $57.00 per share is significantly higher than the option exercise price of $6.82, indicating a substantial gain for the reporting person.
• The transactions were executed under a Rule 10b5-1 trading plan, which demonstrates pre-planning and reduces concerns about opportunistic insider selling.

Negatives

• The Chief Commercial Officer sold 5,600 shares, which represents a reduction in his direct beneficial ownership of Class A Common Stock.

Risks

• While executed under a 10b5-1 plan, any insider selling, regardless of reason, can sometimes be misinterpreted by the market as a lack of confidence, potentially leading to negative sentiment.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider's equity transactions.

Management Comments

• The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape for the telehealth or personal care sectors in which Hims & Hers Health operates. It reflects an individual executive's pre-planned equity management.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even if pre-planned, slightly reduces insider ownership, which some investors might monitor. However, the pre-planned nature under Rule 10b5-1 typically minimizes negative interpretations.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Hims & Hers Health, HIMS, Form 4, Insider Trading, Stock Option Exercise, Rule 10b5-1 Plan, Michael Chi, Chief Commercial Officer, Equity Transaction, Beneficial Ownership